Oesophageal
cancer has been one of the fastest-growing gastrointestinal malignancies in the
world for the past 30-40 years, with cases increasing fourfold. Increased
obesity and oesophageal injury from reflux illness or heartburn, which may be
linked to bigger meal portions, have contributed significantly to this rise during
the previous few decades, says the best gastrointestinal cancer surgeon in
Kolkata.
While
oesophageal cancer is far less common than colon, lung, breast, or prostate
cancer, it is far more difficult to treat since it is discovered at a later
stage. It may also be less responsive to surgical or medicinal treatments than
other malignancies.
When
oesophageal cancer is found, the patient typically has difficulty swallowing
solid foods. This occurs over a period of weeks and may not be discovered until
the cancer has progressed to the point where it has spread to local lymph
nodes, necessitating chemotherapy and radiation therapies to limit the spread —
before surgery.
Because
of the disease's complex, fast-progressing, and fatal nature, it's best to get oesophageal
cancer treated at a specialist centre where multi-modal treatments are used by
experienced teams. The medical and surgical personnel at such a hospital will
discuss each case in a multi-specialty setting.
As
a surgeon who regularly treats GI cancer patients, the cancer doctor reveals
that each patient has a unique anatomy and cancer biology, necessitating a
personalised approach to chemotherapy, radiation, and surgery foroesophageal cancer in Kolkata.
Minimally
invasive surgery is currently the gold standard for oesophageal cancer surgery.
The majority of patients are eligible for this procedure, which uses a surgical
robot or limited access incisions to reduce surgical trauma to the patient to
the greatest extent possible. As a result, patients have spent less time in the
hospital and have recovered more quickly.
These
are few of the current high points in the development and treatment of oesophageal
cancer. According to the GI oncologist in Kolkata, high-quality research
teams from all over the world are collaborating to develop more targeted and
effective pharmacological therapies to combat this malignancy.
0 Comments